Hut 8 Corp vs Indivior Pharmaceuticals Inc. Common Stock — how do they compare? Hut 8 Corp trades at $69.43 (market cap $9.23B), while Indivior Pharmaceuticals Inc. Common Stock trades at $34.25 (market cap $4.03B). The key difference: Hut 8 Corp is far larger — about 2.3× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Indivior Pharmaceuticals Inc. Common Stock is trading nearer its 52-week high, Hut 8 Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hut 8 Corp for 12 Days and Indivior Pharmaceuticals Inc. Common Stock for 0 Days on average.
| HUT | INDV | |
|---|---|---|
Market Cap | $9.23B | $4.03B |
Volume | 12,843,584 | 2,781,171 |
Sector | Financials | Health |
52-Week High | $133.02 | $41.83 |
52-Week Low | $33.76 | $24.09 |
Typical Hold Time | 12 Days | 0 Days |
Enterprise Value | $16.67B | $4.32B |
Signals from Pluang's Aura AI — not financial advice
HUT trades at $83.61, down 1.91% on the day, amid a bearish technical signal. The company reported a net loss of $226.15 million in 2025 with a negative net income margin of 188.59%, though revenue grew to $235.12 million. Recent news highlights a $1.07 billion credit facility and positive analyst coverage, with 16 of 17 analysts rating it a buy and a consensus price target of $163.62.
The outlook is mixed: strong analyst sentiment and AI infrastructure growth potential contrast with persistent losses and high valuation ratios. Key risks include execution on profitability and sensitivity to sector volatility. The stock offers upside if operational improvements materialize but remains speculative given current financials.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Hut 8 is one of North America's largest digital asset miners and infrastructure providers. It operates diversified data centers supporting Bitcoin mining and high-performance computing (HPC) for AI.
Read more on HUT →Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →